A promise for life abbott
-
Upload
mohd-haris -
Category
Healthcare
-
view
51 -
download
2
Transcript of A promise for life abbott
A Promise for life
Company portfolio
Brief History
• Founded by Dr. Wallace
calvin abbott in 1888 in
northern Chicago
• company went public in
1929
• Headquarters at north
Chicago, Illinois, USA
Products
• Two major product groups:
a) diversified medical products include diagnostics,
nutritional products, established pharmaceuticals, and
medical devices
b) research-based pharmaceuticals(core line of business)
• Abbott sells its products in 140 countries, employing over
60000 people
• Largest company in nutritional products and second
largest in diagnostic products
• Abbott’s Established Pharmaceuticals Division(EPD)
Established Pharmaceuticals Division(EPD)
• Headquarters Basel, Switzerland
• Net Sales* $5.1 billion
• Global Leadership Across international markets:
a) No.1 macrolide antibiotic
b) No.1 pancreatic enzyme replacement therapy
c) No.1 progestogen product
• Strong positions in key emerging markets
• EPD does not sell or distribute its products in the
United States.
• Strategy involves building a portfolio that best
meets each local market’s needs.
• Portfolio covers therapeutic areas as
gastroenterology, women’s health, cardiology,
metabolic disorders and primary care
*Brand names vary in different countries
Acquisitions and Revenues
• Recently acquired Chile-based CFR
Pharmaceuticals
• Acquired IDEV Technologies, a stent
manufacturing company, for $310
million net of cash and debt
• Abbott India on Thursday posted 71.42%
rise in its net profit to Rs50.93 crore for
the first quarter ended 30 june
•